Welcome to our dedicated page for Psyched Wellness news (Ticker: PSYCF), a resource for investors and traders seeking the latest updates and insights on Psyched Wellness stock.
Psyched Wellness Ltd. develops and distributes health and wellness products derived from the Amanita Muscaria mushroom. Company news centers on its consumer supplement portfolio, including Calm, Calmer, AME-1 extract and related dietary supplement formats, along with product formulation, shelf-life, safety-study and flavor-profile updates.
Recurring developments also include retail and wholesale distribution relationships in Canada and the United States, manufacturing and supply-chain matters, regulatory and policy commentary affecting botanical wellness products, and board or executive governance changes. The company’s updates often connect product commercialization with route-to-market partnerships and the regulatory risks associated with Amanita Muscaria-derived consumer products.
Psyched Wellness announced the grant of 3,800,000 stock options to its directors, officers, consultants, and employees under its Stock Option Plan. These options will vest in four months and the underlying shares are subject to a four-month hold period as per CSE policies. CEO Jeff Stevens expressed the company's commitment to reward its team for securing a $7.5M USD investment from Gotham Green Partners, ensuring alignment with the company's success. The company aims to boost direct-to-consumer (D2C) sales through its online store and expand its presence in brick-and-mortar retailers. Psyched Wellness is the first to offer Amanita Muscaria products in Erewhon, Market of Choice, and Good Earth Markets. Their proprietary extract, AME-1, is the first legal Amanita Muscaria extract for human consumption in the USA, positioning the company for upcoming retail launches.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.